Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) Sleep apnea is a potentially serious sleep disorder where breathing repeatedly stops and starts. Such a condition prevents the patient's body from getting enough
Monoclonal antibodies (mAbs) are laboratory-produced antibodies that are designed to target and bind to specific proteins or antigens in the body. These antibodies are produced by cloning a single type of immune cell (B cell) or a hybridoma cell line derived from the fusion of a B cell with a tumor cell. Monoclonal.
Rising awareness of sleep apnea along with growth in geriatric population & sedentary lifestyle disorders such as obesity & diabetes are driving market growth.
/PRNewswire/ The "Sleep Apnea Diagnostics Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been.